Filtered By:
Source: BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Condition: Alzheimer's

This page shows you your search results in order of date.

Order by Relevance | Date

Total 4 results found since Jan 2013.

Closed-Loop extracranial stimulation for enhancing cerebral blood Flow in Alzheimer ’s Disease and stroke
Abstract
Source: BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation - January 1, 2023 Category: Neurology Authors: Dennis Turner, Simone Degan, Stephen Schmidt Source Type: research

Feasibility of home-based, self-applied transcranial direct current stimulation to enhance motor learning in middle-aged and older adults
We read with great interest the recent letter sent to you by McConnell and colleagues [1], in which they discuss one of the first applications of truly independent home-based electrical brain stimulation, applied following safety recommendations. Transcranial direct-current stimulation (tDCS) is a non-invasive brain stimulation technique capable of modulating cortical excitability beyond the stimulation period [2,3]. tDCS presents interesting options as a therapeutic intervention in multiple neurological disorders, such as stroke, depression, chronic pain, schizophrenia, and Alzheimer ’s and Parkinson’s disease [4,5].
Source: BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation - September 23, 2019 Category: Neurology Authors: Pablo Maceira-Elvira, Traian Popa, Anne-Christine Schmid, Friedhelm C. Hummel Source Type: research

Does Transcranial Direct Current Stimulation Actually Deliver DC Stimulation: Response to Letter to the Editor
Transcranial direct current stimulation (tDCS) is a common form of transcranial electric stimulation (tES). It delivers constant, low intensity currents to the brain through spongy type electrodes on the scalp [1]. tDCS has been explored for producing behavioral changes and cognitive enhancement in healthy individuals [2]. Furthermore, tDCS may be helpful in attenuating symptoms of neurological disorders such as Parkinson's disease, Alzheimer's disease, schizophrenia, and stroke [3,4]. There are currently no FDA approved indications for its clinical use.
Source: BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation - June 2, 2016 Category: Neurology Authors: Yousef Salimpour, Kelly A. Mills, Zhikui Wei, Phan Q. Duy, William S. Anderson Source Type: research